Recent Press Releases

AstraZeneca to acquire rights to Actavis' branded respiratory portfolio in the US and Canada

Thursday, 5 February 2015 Agreement strengthens AstraZeneca's aclidinium respiratory franchise and adds immediate revenues with long-term growth potential AstraZeneca and Actavis Plc...

Pfizer To Acquire Hospira

Transaction will significantly enhance Pfizer's Global Established Pharmaceutical (GEP) Business Transaction valued at $90 per Hospira share, for a total enterprise value of approximately $17 billion...


Financial results for 2014 in line with upgraded Company guidance given at Q3 2014 results. Full year revenue up 3% at constant exchange rates to $26,095m (FY 2013: $25,711m). Q4 revenue up 2% to...

Sanofi delivers Business EPS(1) growth of 7.3% at CER in 2014

Good sales performance across our various businesses in 2014 · Group sales(2) up 4.9% (+2.5% on a reported basis) to €33,770 million · Growth platforms(3) increased 10.7% to...

ViiV Healthcare Announces $10 Million Initiative to Accelerate Response to HIV/AIDS Among Black Gay and Bisexual Men

Initial Investment to Help Research, Identify and Apply Innovative Solutions in Baltimore, Maryland and Jackson, Mississippi - Two of the Cities Hardest Hit by HIV/AIDS

The Lilly Foundation Commits $1 Million to Support AMPATH Oncology Institute in Kenya

New funding builds on a longstanding partnership to help Kenyans receive quality care


Abbott to Present at Leerink Global Healthcare Conference


Merck Announces Fourth-Quarter and Full-Year 2014 Financial Results

Fourth-Quarter 2014 Non-GAAP EPS of $0.87, Excluding Certain Items; GAAP EPS of $2.54; Full-Year 2014 Non-GAAP EPS of $3.49, Excluding Certain Items; GAAP EPS of $4.07 2015...

Lilly Diabetes Donates $92,000 in Camp Scholarships to the American Diabetes Association

Camps help hundreds of children with diabetes learn lifelong disease management skills


Sanofi and MannKind Announce Afrezza®, the Only Inhaled Insulin, Now Available in the U.S.

Paris and Valencia, Calif. – February 3, 2015 – Sanofi and MannKind Corporation announced today that Afrezza® (insulin human) Inhalation Powder, the only inhaled insulin, is now...

Merck's Insomnia Medicine BELSOMRA® (suvorexant) C-IV, the First and Only Orexin Receptor Antagonist, Now Available in the United States

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that BELSOMRA® (suvorexant) is now available at pharmacies in the United...

Pharma Equities Under the Scanner - Pfizer, Sanofi, Eli Lilly, AstraZeneca, and Zogenix

Editor Note: For more information about this release, please scroll to bottom.

LONDON, February 2, 2015

Zogenix Receives FDA Approval of New Formulation of Zohydro(R) ER

Zohydro ER With BeadTek(TM) to be Available in the Second Quarter of 2015 SAN DIEGO, Jan. 30, 2015 (GLOBE NEWSWIRE) -- Zogenix, Inc. (ZGNX), a pharmaceutical company developing and commercializing...

Vyvanse® (lisdexamfetamine dimesylate) Capsules (CII) Becomes First and Only Treatment Approved by the FDA for Adults with Moderate to Severe Binge Eating Disorder

Lexington, MA – January 30, 2015 – Shire plc (LSE: SHP, NASDAQ: SHPG) announced today that the U.S. Food and Drug Administration (FDA) approved Vyvanse® (lisdexamfetamine dimesylate)...

Merck Repatriates Diabetes and Thyroids Portfolio in Russia to Continue to Drive Emerging Markets Strategy

Move transfers responsibility from marketing partner Takeda to Merck Serono for products in diabetes and thyroid franchises in Russia Transaction reflects company focus on further expansion in...